Cargando…
Risks and Benefits of Clinical Diagnosis Around the Time of Dementia Onset
Diagnostic delay in dementia is common in the U.S. Drivers of diagnostic delay are poorly understood, but appear related to misconceptions about dementia, stigma, concerns about autonomy, the nature of the diagnostic process, and provider-related factors. There is little quantitative evidence underl...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666707/ https://www.ncbi.nlm.nih.gov/pubmed/38026091 http://dx.doi.org/10.1177/23337214231213185 |
_version_ | 1785148989507633152 |
---|---|
author | Power, Melinda C. Willens, Victoria Prather, Christina Moghtaderi, Ali Chen, Yi Gianattasio, Kan Z. Grodstein, Francine Shah, Raj C. James, Bryan D. |
author_facet | Power, Melinda C. Willens, Victoria Prather, Christina Moghtaderi, Ali Chen, Yi Gianattasio, Kan Z. Grodstein, Francine Shah, Raj C. James, Bryan D. |
author_sort | Power, Melinda C. |
collection | PubMed |
description | Diagnostic delay in dementia is common in the U.S. Drivers of diagnostic delay are poorly understood, but appear related to misconceptions about dementia, stigma, concerns about autonomy, the nature of the diagnostic process, and provider-related factors. There is little quantitative evidence underlying cited risks and benefits of receiving a diagnosis around the time of dementia onset, including impacts on physical health, impacts on mental health, care partner interactions, costs of care, increased time for care planning, or earlier access to treatment. While various groups continue to push for reductions in diagnostic delay, realization of benefits and mitigation of harms will require new research on potential benefits and harms. Workforce and resource constraints, coupled with the expected growth in the number of persons living with dementia, may be a barrier to realization of potential benefits and mitigation of identified harms, which will require adequate access to providers, services, and supports. |
format | Online Article Text |
id | pubmed-10666707 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-106667072023-11-22 Risks and Benefits of Clinical Diagnosis Around the Time of Dementia Onset Power, Melinda C. Willens, Victoria Prather, Christina Moghtaderi, Ali Chen, Yi Gianattasio, Kan Z. Grodstein, Francine Shah, Raj C. James, Bryan D. Gerontol Geriatr Med Article Diagnostic delay in dementia is common in the U.S. Drivers of diagnostic delay are poorly understood, but appear related to misconceptions about dementia, stigma, concerns about autonomy, the nature of the diagnostic process, and provider-related factors. There is little quantitative evidence underlying cited risks and benefits of receiving a diagnosis around the time of dementia onset, including impacts on physical health, impacts on mental health, care partner interactions, costs of care, increased time for care planning, or earlier access to treatment. While various groups continue to push for reductions in diagnostic delay, realization of benefits and mitigation of harms will require new research on potential benefits and harms. Workforce and resource constraints, coupled with the expected growth in the number of persons living with dementia, may be a barrier to realization of potential benefits and mitigation of identified harms, which will require adequate access to providers, services, and supports. SAGE Publications 2023-11-22 /pmc/articles/PMC10666707/ /pubmed/38026091 http://dx.doi.org/10.1177/23337214231213185 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Article Power, Melinda C. Willens, Victoria Prather, Christina Moghtaderi, Ali Chen, Yi Gianattasio, Kan Z. Grodstein, Francine Shah, Raj C. James, Bryan D. Risks and Benefits of Clinical Diagnosis Around the Time of Dementia Onset |
title | Risks and Benefits of Clinical Diagnosis Around the Time of Dementia Onset |
title_full | Risks and Benefits of Clinical Diagnosis Around the Time of Dementia Onset |
title_fullStr | Risks and Benefits of Clinical Diagnosis Around the Time of Dementia Onset |
title_full_unstemmed | Risks and Benefits of Clinical Diagnosis Around the Time of Dementia Onset |
title_short | Risks and Benefits of Clinical Diagnosis Around the Time of Dementia Onset |
title_sort | risks and benefits of clinical diagnosis around the time of dementia onset |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666707/ https://www.ncbi.nlm.nih.gov/pubmed/38026091 http://dx.doi.org/10.1177/23337214231213185 |
work_keys_str_mv | AT powermelindac risksandbenefitsofclinicaldiagnosisaroundthetimeofdementiaonset AT willensvictoria risksandbenefitsofclinicaldiagnosisaroundthetimeofdementiaonset AT pratherchristina risksandbenefitsofclinicaldiagnosisaroundthetimeofdementiaonset AT moghtaderiali risksandbenefitsofclinicaldiagnosisaroundthetimeofdementiaonset AT chenyi risksandbenefitsofclinicaldiagnosisaroundthetimeofdementiaonset AT gianattasiokanz risksandbenefitsofclinicaldiagnosisaroundthetimeofdementiaonset AT grodsteinfrancine risksandbenefitsofclinicaldiagnosisaroundthetimeofdementiaonset AT shahrajc risksandbenefitsofclinicaldiagnosisaroundthetimeofdementiaonset AT jamesbryand risksandbenefitsofclinicaldiagnosisaroundthetimeofdementiaonset |